Wordt geladen...
Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma
PURPOSE: We developed polycaprolactone (PCL) implants that achieve zero-order release of a proprietary ocular hypotensive agent (DE-117) over 6 months. METHODS: The release rates of DE-117–loaded PCL devices were tuned based on an established predictive model and confirmed by in vitro release studie...
Bewaard in:
| Gepubliceerd in: | Invest Ophthalmol Vis Sci |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The Association for Research in Vision and Ophthalmology
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5015984/ https://ncbi.nlm.nih.gov/pubmed/27556217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.16-19585 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|